Moderna Plans a $2 Billion Convertible-Note Sale After Last Week’s Cancer-Vaccine Rally

Moderna intends to sell $2B of zero-coupon notes due 2032, plus a $300M option, after a melanoma vaccine rally. Shares slipped on dilution risk.